H.C. Wainwright analyst, reiterated his Buy rating on shares of Synergy Pharmaceuticals (NASDAQ: SGYP) after the company reported topline revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE